Sort   by:  
 Page size 
UnknownA phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas.
Not available
S-EPMC4494099 | biostudies-literature
UnknownCharacterization of the MUC1-C Cytoplasmic Domain as a Cancer Target.
Not available
S-EPMC4534190 | biostudies-literature
UnknownTargeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death.
Not available
S-EPMC4014842 | biostudies-literature
UnknownMUC1-C Oncoprotein Blocks Terminal Differentiation of Chronic Myelogenous Leukemia Cells by a ROS-Mediated Mechanism.
Not available
S-EPMC3107545 | biostudies-literature
UnknownSurvival of human multiple myeloma cells is dependent on MUC1 C-terminal transmembrane subunit oncoprotein function.
Not available
S-EPMC2917857 | biostudies-literature
UnknownMUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.
Not available
S-EPMC5908737 | biostudies-literature
UnknownCooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.
Not available
S-EPMC2820589 | biostudies-literature
UnknownOncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.
Not available
S-EPMC3720729 | biostudies-literature
UnknownMUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC.
Not available
S-EPMC4369171 | biostudies-literature
UnknownMUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.
Not available
S-EPMC2536759 | biostudies-literature
Sort   by:  
 Page size